StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%

Pfizer Total Gross-to-Net Rebate, Chargeback & Return Accruals by Quarter

Total Gross-to-Net (GTN) Rebate, Chargeback & Return Accruals ($M) ($M)

QuarterlyAnnual

Pfizer Total Gross-to-Net Rebate, Chargeback & Return Accruals: $12,128M in Q2 2026, up 4.0% from a year earlier.

Latest, Q2 2026
12,128
Period ended Jun 28, 2026
Change on a year earlier
+4.0%
11,667 in Q2 2025
History
18 quarters
Since Q4 2019
Sources
17
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Ending balance-sheet reserves for U.S. Medicaid, Medicare Part D / IRA, 340B, commercial PBM rebates, wholesaler chargebacks, and product returns (unified across Q1 2026 XBRL axis rename).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Gross-to-Net (GTN) Rebate, Chargeback & Return Accruals ($M) ($M)Year on yearSource
Q2 2026Jun 28, 202612,128+4.0%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 29, 202611,550+5.5%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 202511,666+7.8%Form 10-Q (filed 2026-08-04) ↗
Q3 2025Sep 28, 202512,940+7.0%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 29, 202511,667+24.1%Form 10-Q (filed 2025-08-05) ↗
Q1 2025Mar 30, 202510,945+29.1%Form 10-Q (filed 2025-05-05) ↗
Q4 2024Dec 31, 202410,822+20.1%Form 10-K (filed 2026-02-26) ↗
Q3 2024Sep 29, 202412,097+55.9%Form 10-Q (filed 2024-11-04) ↗
Q2 2024Jun 30, 20249,401+34.5%Form 10-Q (filed 2024-08-05) ↗
Q1 2024Mar 31, 20248,481+27.4%Form 10-Q (filed 2024-05-08) ↗
Q4 2023Dec 31, 20239,014+34.1%Form 10-K (filed 2025-02-27) ↗
Q3 2023Oct 1, 20237,757–Form 10-Q (filed 2023-11-08) ↗
Q2 2023Jul 2, 20236,989–Form 10-Q (filed 2023-08-09) ↗
Q1 2023Apr 2, 20236,656–Form 10-Q (filed 2023-05-10) ↗
Q4 2022Dec 31, 20226,722+14.9%Form 10-K (filed 2024-02-22) ↗
Q4 2021Dec 31, 20215,850+24.3%Form 10-K (filed 2023-02-23) ↗

Breakdown

What makes up total Gross-to-Net Rebate, Chargeback & Return Accruals

Cite this data

StockData. (2026). Pfizer Total Gross-to-Net Rebate, Chargeback & Return Accruals ($M), quarterly Q4 2019–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/gtn-total

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.